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Mesenchymal stromal cells (MSCs) are an adult derived stem cell-like population that
has been shown to mediate repair in a wide range of degenerative disorders. The
protective effects of MSCs are mainly mediated by the release of growth factors and
cytokines thereby modulating the diseased environment and the immune system. Within
the inner ear, MSCs have been shown protective against tissue damage induced by
sound and a variety of ototoxins. To better understand the mechanism of action of
MSCs in the inner ear, mice were exposed to narrow band noise. After exposure, MSCs
derived from human umbilical cord Wharton’s jelly were injected into the perilymph.
Controls consisted of mice exposed to sound trauma only. Forty-eight hours postcell delivery, total RNA was extracted from the cochlea and RNAseq performed to
evaluate the gene expression induced by the cell therapy. Changes in gene expression
were grouped together based on gene ontology classification. A separate cohort of
animals was treated in a similar fashion and allowed to survive for 2 weeks post-cell
therapy and hearing outcomes determined. Treatment with MSCs after severe sound
trauma induced a moderate hearing protective effect. MSC treatment resulted in an
up-regulation of genes related to immune modulation, hypoxia response, mitochondrial
function and regulation of apoptosis. There was a down-regulation of genes related to
synaptic remodeling, calcium homeostasis and the extracellular matrix. Application of
MSCs may provide a novel approach to treating sound trauma induced hearing loss
and may aid in the identification of novel strategies to protect hearing.
Keywords: noise trauma, hearing loss, mesenchymal stroma cells, Wharton’s jelly, cochlear transcriptome,
hearing protection
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the complexity of the induced reactome, it is unlikely that a
single pharmaceutical agent would adequately protect against all
aspects of damage (Rajguru, 2013; Maeda et al., 2017).
Many of the transcriptome changes seen in sound trauma
are also seen in traumatic brain injury (TBI) and stroke,
suggesting common mechanisms and potentially common
approaches to attenuating these injuries (Meng et al., 2017; Li
et al., 2020). An alternate approach to cochlear protection is
treatment of inner ear injury with neuronal or mesenchymal
stem cells/mesenchymal stromal cells (MSCs). MSCs have been
demonstrated to have a wide range of immunomodulatory
and protective effects after tissue injury and have been tested
in diverse disorders such as stroke, acute kidney injury and
myocardial infarction (Squillaro et al., 2016; Fu et al., 2017; Chang
et al., 2018; Cunningham et al., 2018; Harrell et al., 2019; Tsintou
et al., 2020). Fat derived MSCs have been shown to express
growth factors in sound exposed inner ears (Fetoni et al., 2014).
Both peripheral and local delivery of MSCs have been shown to
have protective effects in a variety of hearing loss models but
the molecular consequences of MSC delivery after sound trauma
have not been evaluated [Reviewed in Warnecke et al. (2017);
Kanzaki et al. (2020)].
Mesenchymal stromal cells have been postulated to work
through two distinct mechanisms. When delivered into the
peripheral circulation, MSCs can home into areas of damaged
tissue and through a range of distinct signaling pathways
including TGFβ, CCL2, IL6, IDO, VEGF, and WNT modulate
inflammation and induce tissue protection and repair. It has
been shown that in this delivery approach, the majority of
injected MSCs are trapped in in the pulmonary circulation and
are phagocytosed by pulmonary macrophages. This process of
efferocytosis results in the release of factors inducing immune
tolerance such as IL-10 and TGFβ, which may provide additional
beneficial effects (Galipeau and Sensébé, 2018). Local delivery
of MSCs also induces immunomodulatory and protective effects
through direct delivery of growth factors and extracellular
vesicles in their secretome. Some studies suggest that interaction
between the MSCs and the damaged tissue is needed for the
most complete protective effects (Wakabayashi et al., 2010;
Drago et al., 2013; Hsieh et al., 2013). Local delivery of MSCs
to the brain after TBI has been shown to partially normalize
pathologic gene expression induced by trauma, resulting in
a return to normal immune signaling, receptor mediated cell
signaling, neuronal plasticity and glycolysis (Darkazalli et al.,
2017). This suggests that cell therapy with MSCs has the
capacity to provide multi-mechanistic protection and repair. To
evaluate the mechanisms underlying the effects of MSCs on the
inner ear, we treated adult mice exposed to an acute narrow
band sound trauma with Wharton’s jelly-derived MSCs (WJCs)
directly delivered into the inner ear. Umbilical cord-derived cells
like WJCs, were chosen since they have been shown to have a
secretome that supports neuronal repair (Hsieh et al., 2013). After
treatment, changes in the cochlear transcriptome and in hearing
threshold were evaluated. With this investigative approach, we
identified up and down regulated genes in mice exposed to
noise and treated with WJC when compared to mice exposed to
noise trauma only.

INTRODUCTION
Sound trauma can lead to hearing loss with protean
manifestations. With exposures ranging from acute blast
injury to chronic noise exposure, a wide range of pathological
effects are induced in the cochlea. The degree of injury that
occurs is related to the energy and frequency of the input
sound combined with the time of exposure (Le et al., 2017). At
higher levels of sound exposure, damage to stereocilia and loss
of hair cells in a basal to apical gradient occurs resulting in a
permanent threshold shift. Damage to the spiral ganglion can
occur through excitotoxicity, inflammation and loss of trophic
support (Chen et al., 1997; Puel et al., 1997; Lin et al., 2011).
Additionally, severe sound trauma results in degradation of
the blood labyrinthine barrier. Sound trauma therefore causes
a range of cellular damage that includes both hair cells and
spiral ganglion neurons as well as changes in the cochlear
blood supply. The molecular mechanisms involved in these
processes have been extensively investigated. Initial sound
overexposure results in oxidative stress with overproduction
of reactive oxygen and nitrogen species leading to hair cell
lipid membranes peroxidation and disruption of mitochondrial
homeostasis (Yamane et al., 1995). The mitochondrion has
also been implicated as a primary generator of free radicals
and appears to be intimately involved in the generation sound
trauma related pathophysiology (Kurabi et al., 2017). Multiple
studies have shown that antioxidant defenses and the ability
to buffer free calcium of the cells can prevent noise trauma
(Huang et al., 2000; Gonzalez-Gonzalez, 2017). Ultimately, there
is an activation of a variety of mitogen-activated protein (MAP)
kinase stress pathways including c-Jun N-terminal (JNK) kinase
leading to programmed cell death/apoptosis. Apoptosis can also
be activated through tumor necrosis factor alpha (TNFα), which
is produced during sound trauma (Kurabi et al., 2017). Other
pro-inflammatory cytokines are produced in a delayed fashion
via an nuclear factor kappa-light-chain-enhancer of activated
B-cells (NFκB) signaling cascade (Kurabi et al., 2017). More
recent studies have focused on erythroid two related factor 2
(Nrf2) being a key signal mediator at the center of multiple
pathways (Fetoni et al., 2019). This molecule acts as a reactive
oxygen species (ROS) sensor and normally exists in a bound
state in the cytoplasm. It controls a variety of stress responses
and events such as oxidative stress and inflammation can cause
it to enter the nucleus and activate a variety of signaling cascades
(Fetoni et al., 2019). Evaluation of gene expression networks
after sound trauma has implicated several key pathways in sound
trauma mainly relating to inflammation, heat shock response
and detoxification of ROS (Clifford et al., 2016; Yang et al., 2016).
Changes in regulation of genes related to cytokine signaling and
pathways related to innate immunity appear to play an important
role in the early response to sound trauma (Patel et al., 2013;
Vethanayagam et al., 2016; Yang et al., 2016). Single cell RNAseq
analysis after sound trauma demonstrates that a mix of adaptive
and innate immune cells infiltrate the cochlea after sound
trauma highlighting the complexity of the damage response (Rai
et al., 2020). Antioxidants and anti-inflammatory drugs clearly
can protect against noise induced hearing loss although, given

Frontiers in Cellular Neuroscience | www.frontiersin.org

2

November 2021 | Volume 15 | Article 656930

Warnecke et al.

Treating Hearing Loss With MSC

Auditory Brainstem Response
Measurements

MATERIALS AND METHODS
All animal procedures were approved by the Institutional Animal
Care and Use Board. A total of 25 4 week old female C57BL/6
mice (Jackson Laboratories) weighing between 18 and 23 grams
were utilized for the experiments described below.

For ABR testing, the mice were anesthetized intraperitoneally
using a mixture of ketamine (100 mg/kg) and xylazine
(10 mg/kg). Mice were then placed inside a double-walled, sound
attenuated chamber. Body temperature was maintained at 37◦ C
using a MediHeat V500Vstat Heated Operating Table Digital
Thermostat (PECO Services). ABR measurements were acquired
using the Smart EP program from Intelligent Hearing Systems.
Needle electrodes were placed on the vertex (+), behind the left
ear (−) and behind the opposite ear (ground). Tone bursts were
presented at 4, 8, 16, and 32 kHz, with duration of 500 µs using
a high frequency transducer. Recording was carried out using a
total gain equal to 100 K and using 100 Hz and 15 kHz settings
for the high and low-pass filters. A minimum of 128 sweeps was
presented at 90 dB sound pressure level (SPL). The SPL was
decreased in 10 dB steps. Near the threshold level, 5 dB SPL
steps using up to 1024 presentations were carried out at each
frequency. Threshold was defined as the SPL at which at least
one of the waves could be identified in 2 or more repetitions
of the recording.

Procurement and Expansion of
Mesenchymal Stromal Cells
Human MSCs were isolated from Wharton’s jelly of umbilical
cords according to the protocols approved by the University
of Kansas Human Subjects Committee (KU-Lawrence IRB
approval #15402) and Stormont-Vail (SMV) Hospital (SMV
IRB Approval conferred by IRB Chair, Jo-Ann S. Harris,
MD). Informed consent was obtained from the patients
before collection of the umbilical cords. Three umbilical
cords (n = 3) were obtained from Stormont-Vail (Topeka,
KS, United States). All cords were from males that were
born at full term and delivered under normal delivery
conditions. Human MSCs were isolated and cultured according
to previously published protocols (Mellott et al., 2016).
Cells were cultured in medium consisting of 1% penicillinstreptomycin (Life Technologies), 10% fetal bovine serum (FBS)
mesenchymal stem cell qualified (MSCq) (Life Technologies),
and fibroblast basal medium (Lonza Group Ltd., Basel,
Switzerland), and expanded to passage 5 for all experiments.
For delivery, cells were harvested, washed in phosphate
buffered saline (PBS) and resuspended to a concentration of
1 × 106 cells/ml in sterile PBS.

Sound Exposure
For the noise trauma (sound exposure), the mice were
anesthetized as described above. Mice were then exposed to a
16 kHz pure tone presented at 118 dB SPL in the left ear for
4 h. Sound was delivered through a speaker equipped with a
ribbon tweeter (Radio Shack 40-1310 Horn Super Tweeter). The
speaker was coupled to the left ear via a short plastic tube, 12 mm
in inner diameter and 45 mm in length. Prior to exposure, the
sound output was calibrated using a Quest Electronics Precision
Integrating Sound Level Meter (model 1800). The Sound Level
Meter was calibrated using a 1000 Hz Bruel & Kjaer 4230 Sound
Level Calibrator. After sound exposure, animals were allowed to
recover for 48 h before initiating treatment.

Experimental Design
Three groups were evaluated with five animals in each
experimental condition. Group one consisted of animals (n = 5)
that underwent assessment of baseline hearing by auditory
brainstem response (ABR) followed by MSC delivery into the
left ear. The same animals underwent re-evaluation of hearing
with ABR 7 days post-MSC delivery. Group two animals
were exposed unilaterally to sound followed by treatment with
MSC (n = 5) or artificial perilymph (n = 5) at 48 h postsound trauma. These animals were sacrificed 72 h post-MSC
delivery for extraction of RNA from the treated (left-sided)
cochlea. Group 3 animals were unilaterally exposed to sound
followed by MSC (n = 5) or artificial perilymph (n = 5) at
48 h post-sound trauma. These animals underwent hearing
testing with ABR at 14 days post-cell or perilymph therapy
to evaluate rescue of hearing and thereafter sacrificed for
histological analysis. Group 4 animals were exposed unilaterally
to sound followed by treatment with MSC (n = 8) or artificial
perilymph (n = 8) at 48 h post-sound trauma. These animals
were sacrificed 72 h post-MSC delivery for extraction of RNA
from the treated (left-sided) cochlea (n = 5) or perfused
for immunohistochemistry (n = 3). An additional set of
age matched untreated control animals underwent extraction
of RNA from the cochlea (n = 5) or were perfused for
immunohistochemistry (n = 3).
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Delivery of Mesenchymal Stromal Cells
Mice were anesthetized as described above. A dorsal postauricular incision was made, and the left posterior semicircular
canal exposed. Using a microdrill, a canalostomy was created,
exposing the perilymphatic space. Subsequently 1 µl of MSCs
(1 × 106 cells/ml in sterile PBS) were injected using a Hamilton
microsyringe with 0.1 µl graduations and a 36-gauge needle).
Control animals received 1 µl injection of artificial perilymph
into the canal. The canalostomy was sealed with bone wax. The
mice showed no signs of vestibular dysfunction or head tilt
post-operatively.

RNA Extraction and Analysis
Group 2 animals (noise trauma plus MSC or perilymph
treatment) were anesthetized with Beuthanasia 75 mg/kg
(Schering-Plough Animal Health Corp., Union, NJ, Canada).
The treated (left) cochlea was removed and immediately
placed in RNAlater (Qiagen, cat #76104). Total RNA was
extracted with Trizol reagent (Thermofisher, cat #15596018)
and purified by centrifuging with phase lock heavy gel (Tiagen,

3

November 2021 | Volume 15 | Article 656930

Warnecke et al.

Treating Hearing Loss With MSC

Specimen were then embedded in araldite in a vacuum oven.
The blocks were baked in a 60◦ C oven. Serial sections at
30 µm were performed and stained with toluidine blue. After
air drying, sections were mounted on slides with Permount for
microscopic analysis.
Fog group 4 animals, the temporal bones were removed,
the stapes extracted, and the round window was opened.
The temporal bones were postfixed overnight in 4%
paraformaldehyde in PBS at 4◦ C. After rinsing in PBS
three times for 30 min, the temporal bones were decalcified
in 10% ETDA for 48 h. The temporal bones were rinsed
in PBS, dehydrated, and embedded in paraffin. Ten µm
sections were cut in parallel to the modiolus, mounted on
Superfrost /Plus Microscope Slides (Fisher
Fisherbrand
Scientific, Pittsburgh, PA, United States) and dried overnight.
Samples were deparaffinized and rehydrated in PBS two times
for 5 min, then three times in 0.2% Triton X-100 in PBS for
5 min and finally in blocking solution 0.2% Triton X-100 in
PBS with 10% FBS for 30 min at room temperature. Sections
underwent antigen retrieval in a microwave using 1:10 Dako
Target Retrieval Solution (DAKO Corporation, Carpinteria, CA,
United States) for 30 s. Immunohistochemistry was carried out
with anti-Bcl-2 rabbit polyclonal antibody diluted 1:200 (BD
Biosciences, Inc., San Jose, CA, United States). The tissue was
incubated overnight at 4◦ C in a humid chamber. After three
rinses in PBS, immunohistochemical detection was carried out
with an anti-Rabbit IgG (1:50; Vectastain Elite ABC Kit of
Vector Laboratories, Inc., Burlingame, CA, United States). The
secondary antibody incubated for 3 h at room temperature in
a humid chamber and reactions carried out per manufacturer
instructions. For TNFα immunohistochemistry the tissue
was incubated for 48 h at 4◦ C in a humid chamber in TNFα
polyclonal antibody (1:500, Thermo Fisher, PA5-19810). After
three rinses in 0.2% Triton X-100 in PBS, immunohistochemical
detection was carried out with an Alexa Fluor Donkey 555
anti-Rabbit (1:1000; Abcam). The secondary antibody was
incubated for 6 h at room temperature in a humid chamber.
The slides were rinsed in 0.2% Triton X-100 in PBS three
times for 5 min and finally cover slipped with ProLong Gold
antifade reagent (InvitrogenTM Molecular Probes, Eugene,
OR, United States). For detection of Bcl-2 expression, sections
underwent antigen retrieval in a microwave using 1:10 Dako
Target Retrieval Solution (DAKO Corporation, Carpinteria,
CA, United States) for 30 s. Immunohistochemistry was carried
out with anti-human Bcl-2 rabbit polyclonal antibody diluted
1:200 (BD Biosciences, Inc., San Jose, CA, United States). The
tissue was incubated overnight at 4◦ C in a humid chamber. After
three rinses in PBS, immunohistochemical detection was carried
out with an anti-Rabbit IgG (1:50; Vectastain Elite ABC Kit of
Vector Laboratories, Inc., Burlingame, CA, United States). The
secondary antibody incubated for 3 h at room temperature in
a humid chamber.

cat # WMS-2302830). Concentration and quality of RNA were
assessed using an Agilent Bioanalyzer 2100. Analysis of cochlear
RNAs was carried out using the NuGen Universal Plus Assay on a
NovaSeq sequencer as per manufacturer instructions. Trimming,
quality control and alignment was carried out using the A.I.R.
software package1 with noise damage only specimens as a
reference and noise damage with MSC treatment as the analyzed
data package. There were five replicates for each experimental
condition. The C57Bl/6 mouse genome (C57Bl6NJvi/ENSEMBL
release) was used as a reference genome. Statistical analysis
was carried out by the NOISeq method. Up regulated and
down regulated genes were identified and organized according
to their gene ontology (GO) classification. A combination of
the enrichment score and the false discovery rate (FDR) was
then used to develop a gene ontology enrichment analysis
(GOEA). Analysis of potential biological significance was carried
out using Ingenuity Pathway Analysis (IPA) software (Qiagen
Bioinformatics, Redwood City, CA, United States) and the
Reactome Knowledgebase2 (Jassal et al., 2019). Using the IPA
software package, results were organized into the most common
pathways that were altered in response to MSC treatment and
which keys genes were up or down regulated. The most up and
down regulated genes were additionally evaluated using Pharos
software3 for identification of molecules in clinical use that can
down or up-regulate the identified genes.
Expression of bcl2 and tnf was quantified in group 4 animals.
cDNA from the control, noise exposed and noise + MSC samples
was synthesized using the miScript II reverse transcription kit
(Qiagen, cat#218161). Semi quantitative PCR for bcl-2 and tnf
(Origene cat MP201255; NM013693) was then performed on the
Bio-Rad CFX using the Quantitect SYBR Green PCR kit (Qiagen,
cat# 204141). Tranthyretin expression was measured using the
Bio-Rad qMMuCID0006861 primer pairs.
All reactions were performed in triplicate and the Cq value
was determined using the threshold calculated by the Bio-Rad
software. Fold change was calculated using the 2−11CT method.

R

R

Histological Analysis

R

Group 3 animals were anesthetized with Beuthanasia (Merck
Animal Health) 14 days after treatment with MSCs or
artificial perilymph and fixed via intracardiac perfusion with
4% paraformaldehyde in PBS. The cochleae were removed
and postfixed in 2.5% glutaraldehyde, 1.5% paraformaldehyde
in 0.1 M phosphate buffer overnight at 4◦ C. Cochleae were
decalcified in 1% glutaraldehyde in 0.12 M ethylene diamine
tetraacetic acid (ETDA) in 0.1 M phosphate buffer for 4 days
at 4◦ C. The specimen were then stained with osmium 1% for
1 h. After washing in distilled water specimens were dehydrated
in a graded series of ethanol. After 30 min in propylene oxide
(obtained from Electron Microscopy Sciences, Hatfield, PA,
United States #20401), cochleae were transferred to araldite/P
mix (obtained from Electron Microscopy Sciences, Hatfield, PA,
United States #10900) and kept on a rotating shaker overnight.

R

Statistical Analysis
Statistical analysis of hearing outcomes was performed with
ANOVA for repeated measures. RT PCR results were analyzed
using ANOVA (Prism V8).

1

sequentiabiotech.com
2
reactome.org
3
Pharos.nih.gov
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RESULTS
Delivery of Mesenchymal Stromal Cells
to the Mouse Cochlea Does Not Induce
Hearing Loss
After documentation of baseline hearing by ABR, 1 month old
C57Bl/6 mice (n = 5) underwent delivery of 1 µl of human
Wharton’s Jelly-derived MSCs into their left posterior semicircular canal. One week post-delivery of cells, their hearing was
re-evaluated. ABR recording prior to treatment at 4, 8, 16, and
32 kHz showed an average hearing threshold of 28.3 ± 7, 35 ± 5,
30 ± 5, and 30 ± 17, respectively. The average hearing threshold
for each frequency did not change significantly after cell therapy
(30 ± 0, 35 ± 5, 30 ± 0, and 40 ± 17 for 4, 8, 16, and 32 kHz,
respectively) (Figure 1).

FIGURE 2 | Delivery of MSCs rescue hearing after noise exposure. Exposure
to sound for 4 h results in a profound hearing loss across all frequencies
(medium gray bars; Control Post). Delivery of MSCs into the posterior
semicircular canal of animals after sound exposure resulted in significant
rescue of hearing at 4 and 8 kHz (p < 0.01**) as well as at 32 kHz (p < 0.05*)
(light gray bars; MSC treated Post) when compared to the control animals
treated with artificial perilymph (Control Post).

Delivery of Mesenchymal Stromal Cells
to the Mouse Inner Ear Provides
Significant Hearing Rescue After Severe
Noise Trauma
Pre-treatment ABR measurements showed normal hearing
threshold in both groups (Figure 2; control ore and MSC treated
pre). After noise exposure, animals of the control group (treated
with artificial perilymph) demonstrated a severe to profound
hearing loss across all frequencies at 14 days post-sound exposure
(Figure 2; control post). There was a significant rescue effect seen
in the MSC treated animals at 4 and 8 kHz (p < 0.01) and at
32 kHz (p < 0.05) (Figure 2; MSC treated post) when compared
to the thresholds of the control group after noise exposure and
application of artificial perilymph (Figure 2; control post). At
16 kHz, treated animals showed better hearing thresholds than
sound trauma and artificial perilymph treated animals, but this
was not statistically significant. Histological analysis of the organ
of Corti performed separately for the basal and mid turn showed
loss of hair cells both inner and outer hair cells for both groups

FIGURE 3 | Histological evaluation of organ of Corti integrity in sound trauma
(A,C) and sound trauma and MSC (B,D) treated cochlea. Loss of inner hair
cells is consistently seen in the basal turns of both groups (A,B). The MSC
treated group showed occasional survival of inner hair cells at the midturn (D).

after sound trauma (MSCs and artificial perilymph treated) in
the basal turn (Figures 3A,B). When compared to the artificial
perilymph treated animals (Figure 3C), the MSC-treated animals
did show preservation in the mid turn of the cochlea (Figure 3D).
DPOAEs were not measurable after sound trauma and were not
restored by MSC therapy (data not shown).

Delivery of Mesenchymal Stromal Cell
Alters Cochlear Gene Expression
For control cochleae, an average of 155 ng/µl of RNA and for
MSC treated cochleae 182 ng/µl of RNA were extracted. An
average of 13,789,205 and 13,472,844 input reads for control and
MSC treated cochleae were performed yielding 15,671 mapped
genes. Delivery of MSCs caused a greater down-regulatory than

FIGURE 1 | Delivery of MSCs did not have any effect on baseline hearing.
Hearing thresholds measured by ABR at four different frequencies prior to
(black bars) and 7 days after transplantation of MSC to the inner ear via the
posterior semicircular canal (gray bars) are depicted. There is no significant
difference between the pre- and post-transplantation thresholds.
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ion channel activity, voltage gated ion activity, syntaxin-1
binding, sodium channel activity and calcium channel activity
were found. Interestingly, processes relating to dynein light
and intermediate chain binding were also seen. The GO terms
relating to cellular components concentrated on the excitatory
synapse, components of the axon, dendrites, and myelin sheath
as well as mitochondrion related annotations (Figure 5).
Voronoi tree-maps that improved hierarchical representation
of the GOEA data were additionally evaluated and groups
of genes that appear significantly represented were identified
(Bernhardt et al., 2009).
Down-regulated genes included miRNAs such as miR-9,
miR-124a, miR-124-2, and miR-133a. Regulation of heat shock
proteins has been implicated in sound trauma and in this data
set, delivery of MSCs resulted in down-regulation of Hspa1b,
Hsp1l, Hsph1, Ahsa1, Hsp9, and Hsp90ab1 (Gratton et al., 2011).
Key effectors of cell death were also down-regulated whereas
protective genes such as bcl-2 were up-regulated.
Up-regulated genes were enriched for processes involved
in adaptive and innate immune responses, extracellular matrix
organization, cell adhesion and a wide range of cell repair
and developmental processes (Table 1). Additional processes
included transcription factor function, wound healing, regulation
of apoptotic process and response to hypoxia. Molecular function
annotations centered on a range of protein receptor signaling
processes and processes related to matrix binding. Signaling
processes related to insulin like growth factor binding, TGFβ,
fibroblast growth factor and Wnt binding were represented.

up-regulatory effect on gene expression in sound traumatized
animals treated with MSCs. A total of 2742 genes were downregulated, and 1138 genes were found to be up-regulated.
Significantly changed genes were considered to have an FDR of
<0.05 and two fold change (up or down). Key down-regulated
genes are shown in Supplementary Table 1 and up-regulated
genes are shown in Supplementary Table 2.

Analysis of Gene Ontologies and
Functional Networks
The effects of MSC delivery after sound trauma were evaluated
using GO expression analysis using IPA “Core” and “Bioprofiler”
analysis. The GO classification for genes that are regulated by
MSC delivery were broken down into the biological processes,
molecular functions and cellular components and weighted
according to their enrichment (FPKM) and FDR score. These
were also visualized as a Voronoi tree plots to facilitate
identification of key pathways. Down-regulated genes were
enriched for processes related to neuronal function and repair
with ion transport, nervous system transport, positive regulation
of synapse assembly, modulation of synaptic transmission,
regulation of membrane potential, synaptic transmission,
regulation of post-synaptic membrane potential and long-term
synaptic potentiation GO classifications dominating (Figure 4).
The GO molecular function classification showed significant
changes in genes related to protein binding although these
were not highly enriched. Genes related to transmitter-gated

FIGURE 4 | Down-regulated biological processes classified by gene ontology. The size of the category corresponds to a lower FDR with the more deeply red groups
representing a higher enrichment score. The graphic representation of gene expression demonstrates that a key element in MSC treatment is modulation of synaptic
assembly which is represented in multiple groups of down-regulated genes.
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FIGURE 5 | Up-regulated biological processes classified by gene ontology. The size of the category corresponds to a lower FDR with the more deeply red groups
representing a higher enrichment score. Up-regulation of genes related to immune function are a key component of MSC treatment.

Annotations showed that these genes were related to the
cell surface, the extracellular matrix and the Golgi apparatus.
Processes involving membrane repair and transmembrane

tyrosine kinase signaling were also represented. Also represented
were processes such as negative regulation of neuronal apoptosis,
protein stabilization and sensory response to sound, which we
would expect to see in a repair process involving the inner ear.
Up-regulated genes related to response to sound are specific to
the ear, associated with development of the inner ear, associated
with syndromes that include hearing loss or when mutated
are associated with sensorineural hearing loss (Shearer et al.,
1993). We identified 14 up-regulated genes including Myo1A
(Kwon et al., 2014), Ripor2 (Diaz-Horta et al., 2018), Nipbl,
Ccdc50 (Modamio-Høybjør et al., 2007), Lhfpl5 (Ge et al., 2018),
Fgfr1 (Pirvola et al., 2002), Diaph1 (Neuhaus et al., 2017),
Pou4f3 (Walters et al., 2017), P2rx2 (Mittal et al., 2016), Otog
(Schraders et al., 2012), Otoa (Lukashkin et al., 2012), Cntn5,
Icam1 (Schmutzhard et al., 2011), and Hexa. The identified
genes ranged from hair cell, spiral ganglion and stria specific
to affecting tectorial membrane function, emphasizing that the
MSC treatment affects multiple areas of the inner ear. Treatment
with MSC resulted in both up and down regulation of genes
that have been associated with noise induced hearing loss
in other studies. Regulation of complement and toll receptor
signaling has been shown to be associated with noise induced
hearing loss (Patel et al., 2013; Vethanayagam et al., 2016; Yang
et al., 2016). Members of the complement cascade identified
included C1qtnf4, C1ql2, and Cfd (down-regulated) and C1rl
and C3 (up-regulated). Other members of the innate immune
system that showed differential expression were members of the
Toll signaling system including Tlr4, Tlr6, and Tiarp, which
were up-regulated. To more clearly identify effects of cell

TABLE 1 | Down- and up-regulated canonical pathways.
Down-regulated
canonical pathways

Up-regulated canonical pathways

Calcium Signaling

Cardiovascular Disease, Cardiovascular System
Development and Function

Synaptogenesis
Signaling Pathway

Cancer, Organismal Injury and Abnormalities

GABA Receptor
Signaling

Cell-To-Cell Signaling and Interaction, Hematological
System Development and Function, Inflammatory
Response, Organismal Functions

Endocannabinoid
Neuronal Synapse
Pathway

Hematological System Development and Function,
Immune Cell Trafficking, Inflammatory Response, Tissue
Development

Oxidative
Phosphorylation

Cancer, Hematological Disease, Immunological
Disease, Organismal Injury and Abnormalities

Opioid Signaling
Pathway

Connective Tissue Development and Function, Skeletal
and Muscular System Development and Function,
Tissue Development

Mitochondrial
Dysfunction

Cancer, Gastrointestinal Disease, Organismal Injury and
Abnormalities

GNRH Signaling

Cellular Function and Maintenance

Synaptic Long Term
Depression

Cell-To-Cell Signaling and Interaction, Cellular Function
and Maintenance, Inflammatory Response

Corticotropin Releasing
Hormone Signaling

Cancer, Gastrointestinal Disease, Organismal Injury and
Abnormalities
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controls (p = 0.0021; p = 0.0002) but were not significantly
different from each other (p = 0.2517). IPA comparison analysis
(Figure 6) also identified NeuroD1 as a significantly downregulated transcription factor that is predicted to modulate
multiple pathways related to neuronal growth and survival.
Many of the survival effects are mediated through neurotrophin
signaling. One of the downstream effects of neuroD signaling are
alterations in the balance of bcl-2 and bax modulating apoptosis
(Wy, 2013). MSCs have also been shown to modulate bcl-2
expression in a variety of injury models (Xiang et al., 2009;
Gu et al., 2014). Our data showed that there was a 0.4 fold
up-regulation of bcl-2 in MSC treated animals vs. sound only
controls. There were no identifiable changes in bax expression
in our data suggesting induction of an anti-apoptotic state.
This was confirmed using immunohistochemistry and RT-PCR
(Figure 8). MSC treated animals showed an increase of bcl2 immunolabeling in the organ of Corti, particularly in the
supporting cells (Figure 8C) and demonstrated an up-regulation
of bcl-2 mRNA (Figure 8D). One of the most down-regulated
genes identified in our study was transthyretin (5.377 fold
decrease in expression after MSC treatment). Transthyretin plays
multiple roles in the nervous system and is a key modulator
of metabolism, which was predicted to be altered in the IPA
comparison analysis (Figure 6). We confirmed down-regulation

therapy the IPA software was used to compare only significantly
up- and down-regulated genes to evaluate the relationship
between expression data and potential pathways involved
in injury and protection. Key canonical pathways identified
were calcium signaling, synaptogenesis signaling, endocaniboid
neuronal synapse pathway, GABA receptor signaling and CREB
signaling in neurons. Key predicted upstream regulators include
BDNF, which has been shown to be produced by MSCs and
has been identified as a mechanism of MSC protection of
neurons in stroke models (Gu et al., 2014; Mukai et al.,
2018). When graphically represented, TNFα can be seen as
playing a central role in the predicted changes in biological
function and signaling pathways (Figure 6). This was further
evaluated using immunohistochemistry and semi quantitative
PCR (Figures 7–9). Immunofluorescent labeling showed that
MSC therapy reduced expression of TNFα protein in the
lateral wall (Figures 7B vs. C), however expression was higher
than controls in the inner hair cells of both sound trauma
only (Figure 7B) and sound trauma + MSC treated animals
(Figure 7C). RNAseq analysis demonstrated a 0.8 fold upregulation of TNFα mRNA in MSC vs. sound trauma treated
animals. Evaluation using RT-PCR demonstrated that both
sound trauma only and sound trauma + MSC treated animals
showed significantly up-regulated mRNA levels compared to

FIGURE 6 | Graphical representation of IPA analysis of up- and down-regulated genes and processes. Using IPA core analysis of down-regulated genes and
processes (blue) predicted up-regulation of genes and processes (orange). There is an overall down-regulation of pathways related to synaptogenesis, development
of neurons and excitatory signaling. TNFα is a key factor that influences multiple processes and genes.
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FIGURE 7 | Expression of TNFα protein (Red A–C) and semi quantitative RT PCR of TNFα mRNA (D). Control cochlea showed minimal TNF expression in the hair
cells and lateral wall (A). After sound trauma there was a clear increase in TFN alpha immunolabeling in hair cells, the spiral ganglion (arrow) and the lateral wall (B).
Treatment with MSCs after sound trauma reduced TNFα expression in the lateral wall and outer hair cells but expression remained high in the inner hair cell (arrow
C). Semi quantitative RT-PCR showed an up-regulation of TNF gene expression after sound trauma. This was slightly reduced after MSC treatment but not to control
levels (D).

group. The changes underlying the altered threshold could also
be the result of damage to other regions, for example of the
stria vascularis or the synapses. Since the focus of the present
study was the functional restoration and RNA changes induced
by cell therapy rather than the histological changes, synapses
and the stria vascularis were not investigated. We identified
more than 2700 down-regulated and 1138 up-regulated genes
after treatment with WJC. To understand the biological effects
of the differentially regulated genes, the cellular components,
molecular function, and biological process were analyzed by
GO annotation. Using IPA, specific analysis of genes related to
cell death and survival showed the regulation of 365 molecules
related to necrosis and 353 molecules related to apoptosis with
a predictive effect of decreasing both death mechanisms and
increasing cell survival. We could demonstrate that there are
MSC induced reductions of TNFα expression in the cochlear
lateral wall (Figure 7) and MSC induced increases in bcl2 expression in the organ of Corti (Figure 8). TNFα upregulation has been associated with sound trauma (Frye et al.,
2019). Our data demonstrated an up-regulation in TNFα gene
expression which could not be confirmed by PCR (Figure 7D).
However, distribution of TNFα expression was reduced in
the lateral wall of the cochlea (Figures 7C vs. B). Increased
expression of TNFα in the sound damaged cochlea has been
demonstrated for days 1–3 post-sound trauma followed by a

of transthyretin by semi quantitative RT-PCR (Figure 9). Finally,
we identified molecules in clinical use that could modulate most
significantly regulated genes, identifying 46 drugs that could
potentially be used to study some of the effects induced by MSCs
(Table 2). Transthyretin can be down-regulated using thyroxine
hormone (T4). Based on the Pharos analysis, multiple modulators
of GABA neurotransmission are available, raising the possibility
of using small molecules to modulate this pathway.
Besides neurotrophins, MSCs produce a variety of
immunomodulatory molecules and other growth factors.
Using the predictive functions of IPA, we analyzed the potential
effect of several growth factors and cytokines known to be
delivered by MSC on our data set and found that the observed
changes in HSP90, complement factor 3 and toll like receptor 4
could potentially be modulated by MSCs (Figure 10).

DISCUSSION
Intra-labyrinthine application of WJCs after noise trauma
showed significant protection of hearing threshold at the lower
frequencies at 4 and 8 kHz and to a lesser degree at 32 kHz
in mice. Histological changes related to sound trauma could
be identified in the organ of Corti in both groups. There was
preservation of some mid turn hair cells in the MSC treated
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FIGURE 8 | Expression of bcl-2 (brown A–C) and semi quantitative RT PCR of bcl-2 mRNA (D). Control cochlea showed bcl-2 expression in the pillar, in the inferior
portion of the outer hair cells (arrows) and neurites (A). After sound trauma there was an occasional increase in bcl-2 immunolabeling in isolated supporting cells
(arrow) (B). Treatment with MSCs after sound trauma increased expression of bcl-2 in supporting cells (arrow C). Semi quantitative RT-PCR showed reduction of
bcl-2 mRNA expression after sound trauma. Treatment with MSC after sound trauma showed a significant up-regulation of bcl-2 mRNA compared to both controls
and sound trauma only treated animals (p = 0.003) (D).

treatment of brain injury and many of the drugs that are
in experimental or clinical trials (Diaz-Arrastia et al., 2014)
may also be applicable to the inner ear. Use of the Pharos
database identified that 46 of the most up and down regulated
genes could potentially be targeted by molecules that are
already in use. NMDA receptors in particular have already
been targeted in clinical trials for sound induced tinnitus,
demonstrating that MSC induced protection in part functions
through previously identified mechanisms (Bing et al., 2015;
Staecker et al., 2017).
In the cellular component category, the most represented
term is “AMPA glutamate receptor complex,” followed by “postsynaptic density membrane” and “excitatory and inhibitory
synapses” for the down-regulated genes. In the molecular
function category, the term “transmitter-gated ion channel
activity involved in regulation of post-synaptic membrane
potential” and “syntaxin-1 binding was found to be represented.
The underlying biological processes in the down-regulated
genes were related to synaptic functions. Most striking,
synapse-specific processes like excitatory as well as inhibitory

decrease and then a further expression increase at 28 days
post-noise exposure (Fujioka et al., 2006). Additional time
points will be needed to evaluate the long term effects of
MSC treatment. We additionally evaluated the effect of MSC
treatment on bcl-2 expression in the sound damaged inner ear.
Our RNAseq data demonstrated a down-regulation of cell death
effector genes and an up-regulation of the antiapoptotic bcl-2
(Figure 8) consistent with other MSC experiments (Gu et al.,
2014). Up-regulation of bcl-2 has been shown to be an underlying
mechanism in sound conditioning protection from noise trauma
(Niu et al., 2003).
Many of the identified genes and GO annotations have
been found in or belong to a similar GO pattern seen in
stroke or TBI suggesting that severe sound trauma and TBI
(Spaethling et al., 2008; Darkazalli et al., 2017; Meng et al.,
2017; Trivedi et al., 2019; Li et al., 2020) involve similar
molecular mechanisms. By evaluating the diverse pathways
activated in this recovering system, we may be able to select
new targets for the pharmacological mitigation of sound trauma.
Significant advances have been made in the pharmacologic
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TABLE 2 | Pharos analysis of genes showing greatest up- and down-regulation
that can be modulated by small molecules in clinical use.

FIGURE 9 | Expression of cochlear transthyretin by semi quantitative RT-PCR.
Sound trauma treated animals showed a relative increase in expression of
transthyretin mRNA. MSC treatment resulted in a significant reduction in
expression of transthyretin mRNA after sound trauma (p = 0.001).

synapse, AMPA glutamate receptor complex synapse assembly,
regulation of post-synaptic membrane potential, modulation
of synaptic transmission and long-term synaptic potentiation
were significantly down-regulated. This suggests that neuronal
repair and control of excitotoxicity could be key components
of recovery from severe sound trauma. For the up-regulated
genes, “trans-Golgi network transport vesicles” is the most overrepresented term in the cellular component category. Looking
at molecular functions, extracellular binding, Wnt-protein and
insulin-like growth factor binding were most abundant alongside
with cytokine receptor activity. In the biological processes
category, the terms extracellular matrix organization, adaptive
immune response as well as transmembrane receptor protein
tyrosine kinase (Trk) signaling pathway were found to be
strongly represented. Immunomodulation and activation of
Trk signaling pathways are known to be potent enhancers of
survival. For example, systemic transplantation of MSC in a
TBI model led to a lower density of microglia, macrophages as
well as peripheral infiltrating leukocytes at the injury site, to
reduced levels of pro-inflammatory cytokines and increased antiinflammatory cytokines (Zhang et al., 2013). Even in a model
of xenotransplantation of MSC derived from adipose tissue after
ventral root avulsion, an increased neuronal survival and partial
preservation of synaptophysin-positive nerve terminals as well as
a reduction of pro-inflammatory reactions were elicited (Ribeiro
et al., 2015). It is assumed that by suppressing lymphocyte,
astroglia and microglia effects, MSC can prevent a second delayed
neuronal injury (Ribeiro et al., 2015). Furthermore, MSCs can
prevent neuronal cell death not only via restoration of the local
microenvironment but also by the release of classic inhibitors of
apoptosis (Tran and Damaser, 2014).
Looking at the top down-regulated genes, mainly genes
coding for transcription factors or for proteins and receptors
related to synaptic function are among the most regulated.
Down-regulation of oxidative stress pathways might be key
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Symbol

Gene name

Symbol

Cacna1a

Voltage-dependent calcium
channel subunit
alpha-1/alpha

Hrh3

Histamine H3 receptor

Cacna1i

Voltage-dependent T-type
calcium channel subunit
alpha

Htr2c

5-hydroxytryptamine
receptor 2C

Car4

Carbonic anhydrase 4

Cck

Cholecystokinin

Kcnd2

Potassium voltage-gated
channel subfamily D
member 2

Ccl3

C-C motif chemokine 3

Kcnh6

Potassium voltage-gated
channel, subfamily H,
member 6

Cnr1

Cannabinoid receptor 1

Kcns2

Potassium voltage-gated
channel subfamily S
member 2

Gabra1

Gamma-aminobutyric acid
receptor subunit alpha-1

Krt1

Keratin, type II
cytoskeletal 1

Gabra4

Gamma-aminobutyric acid
receptor subunit alpha-4

Lipf

Gastric triacylglycerol
lipase

Gabra6

Gamma-aminobutyric acid
receptor subunit alpha-6

Muc1

Mucin 1, transmembrane

Gabrb1

Gamma-aminobutyric acid
receptor subunit beta-1

Ngf

Beta-nerve growth factor

Gabrb2

Gamma-aminobutyric acid
receptor subunit beta-2

Pou1f1

Pituitary-specific positive
transcription factor 1

Gabrp

Gamma-aminobutyric acid
receptor subunit pi

Prl

Prolactin

Gal

Galanin peptides

Prlr

Prolactin receptor

Gh

Growth hormone

Rnf112

RING finger protein 112

Gnrhr

Gonadotropin releasing
hormone receptor

Scn2a1

Sodium channel protein

Gp2

Pancreatic secretory
granule membrane major
glycoprotein GP2

Slc5a1

SGLT1 protein

Gria1

Glutamate receptor 1

Slc6a1

Sodium- and
chloride-dependent GABA
transporter 1

Gria2

Glutamate receptor 2

Slc6a5

Sodium-dependent
noradrenaline transporter

Grik2

Glutamate receptor
ionotropic, kainate 2

Sstr3

Somatostatin receptor
type 3

Grin2a

Glutamate receptor
ionotropic, NMDA 2A;
NMDA 2B; NMDA 2D

Stum

Protein stum homolog

Grin2b

Glutamate receptor
ionotropic, NMDA 2B

Tnr

Grin2c

Glutamate receptor,
ionotropic, NMDA2C

Trpm8

Grm5

Metabotropic glutamate
receptor 5

Irs4

Ttr

Gene name

Insulin receptor substrate 4

Tenascin-R
Transient receptor potential
cation channel subfamily M
member 8
Transthyretin

for the mediation of protective effects. According to our RNA
sequencing data, transthyretin (Ttr), a neuronal stress marker,
is one of the most significantly down-regulated genes by the
application of MSC after noise-induced trauma. It has been
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proteins that are involved in the response to stress and metabolic
damage to the inner ear such as Hspa1b, Hsp1l, Hsph1, Ahsa1,
Hsp9, and Hsp90ab1 are also down-regulated by MSC treatment
(Sheehan-Rooney et al., 2013).
Moreover, several transcription factors, e.g., BarHl2, Neurod2,
EN2, and Pax6, are down-regulated by application of MSC in
noise trauma as demonstrated by our results. The homeobox
protein BarH-like 2 (Barhl2) acts as transcription factor and
possesses an enhancer that can be activated by the basic helixloop-helix factor Atoh1 and can drive spinal cord-specific
gene expression. Interestingly, this gene is significantly downregulated when comparing noise-damaged cochlea treated with
MSC to the sham-treated. Similar is observed for the neuronal
differentiation factor 2, Pax6 and homeobox protein engrailed2 (EN2). The later may alter the excitation/inhibition balance,
and its down-regulation may rescue or regain homeostasis by
MSC to reduce damage. NeuroD2 and Pax6 are important
regulators of neuronal development in the central nervous
system and their down-regulation after treatment with MSC
seems quite surprising (Yogarajah et al., 2016). Whether
damage leads to dedifferentiation and induction of neurogenesis
thereby making the inner ear more susceptible to secondary
damage mediated by oxidative stress and therewith associated
metabolites remains speculative and needs further investigation.
In addition to neuronal development, NeuroD2 balances synaptic
neurotransmission and intrinsic excitability in the adult system,
thereby decreasing neuronal excitability of cortical pyramidal
neurons both in vitro and in vivo (Chen F. et al., 2016). After
trauma, as has been shown for example in models of TBI,
there is an excitation/inhibition imbalance as also reflected by
the GABA/glutamate imbalance. Excitatory pathways in the
brain are regulated by GABA and loss of GABA releasing
cells after trauma further enhances cell injury and apoptosis
(Guerriero et al., 2015). Although glutamate is the excitatory
transmitter in the brain required for proper function, posttraumatic burst release of glutamate leads to excitotoxicity and
subsequent cellular injury as has been also shown after noiseinduced damage of the inner ear. By down-regulation of both,
glutamate and GABA receptor subunits, MSC might down
regulate the neuronal activity thereby possibly preventing further
damage and transforming the cochlea to a state for protection
and regeneration. The availability of multiple small molecules
modulating this pathway (Table 2) raises the possibility of novel
treatments of sound trauma.
Several miRNAs (miR-9, miR-124a, miR-124-2, and miR133a) are also down-regulated after treatment with MSCs.
These miRNAs play a variety of important developmental
roles; miRNA-9 is the most significantly up-regulated miRNA
in the developing brain, targeting the transcription factors
FoxG1, Hes1, or Tlx, thereby playing an important role in
the regulation of neuronal progenitors (Coolen et al., 2013).
MicroRNA-9 has also been shown to regulate Schwann cell
migration in neuronal injury, and is thought to play an
important role in peripheral neuronal repair (Zhou et al.,
2014). Similarly, miRNA-124a is an important developmental
regulator and is involved in neurogenesis of the hippocampus
and retinal cones (Sanuki et al., 2011). This miRNA has

FIGURE 10 | The known WJC secretome regulates multiple genes found to
be altered after sound trauma and MSC delivery. Components of the WJC
secretome (boxed area) were evaluated for potential interactions with genes
that we found to undergo significant change using the IPA knowledgebase.
This demonstrates the potential biological basis for the protective effects that
WJCs have on noise trauma.

shown that Ttr level correlate with ROS or reactive nitrogen
species (RNS) (Saito et al., 2005; Fong and Vieira, 2013).
In addition, the expression of the Ttr gene is regulated by
glucocorticoids, which are stress hormones (Li et al., 2011;
Martinho et al., 2012). On a protein level, Ttr can initiate
oxidative stress in the endoplasmic reticulum and is thereby
involved in the unfolded protein response (UPR) (Teixeira
et al., 2006; Genereux et al., 2015; Chen J. et al., 2016). Thus,
down-regulation of ttr might result in inhibition of formation
of reactive oxygen and nitrogen species thereby reducing the
extent of trauma-associated damage. Recent TBI studies using
drop-seq have demonstrated that up-regulation of ttr is one
of the major markers of trauma in a wide range of cell types
(Arneson et al., 2018). This study also documented functional
recovery induced by dosing TBI animals with thyroxine (T4)
which down-regulates transthyretin. We demonstrated an MSC
induced normalization of ttr gene expression by RNAseq and
semiquantitative PCR (Figure 9) raising the possibility that
thyroxine could be used to limit sound trauma induced damage.
Other factors involved in the production of ROS belong to the
kallikrein-kinin system. This system includes plasma or tissue
related kinins and they mediate vascular permeability, edema
formation, inflammation and the release of glutamate in the case
of neurodegenerative disease associated with neuroinflammation
such as TBI or Alzheimer’s disease (Naffah-Mazzacoratti Mda
et al., 2014; Hopp and AlbertWeissenberger, 2015). Tissuederived kallikreins belong to the chymotrypsin- and trypsinlike serine endopeptidases. Especially kallikrein-7, originally
identified as an inflammation−induced proteolytic enzyme in the
skin, is down regulated by the application of WJS after sound
trauma (Kidana et al., 2018). In addition, stress-related heat shock
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ear protection after noise trauma have been identified by applying
pathway enrichment analysis. In future studies, we could mimic
the effects of MSCs or inhibit potential protective pathways with
small molecules to better characterize regulatory pathways by
using large-scale transcriptome analysis in well-defined sets of
experiments (Islam et al., 2019).

also been shown to be up-regulated in repetitive brain injury
(Huang et al., 2018). Therefore, the down-regulation of miR124 observed in this study may represent a positive effect of
MSC treatment. Both miR-9 and -124 have been identified as
biomarkers of TBI (Ji et al., 2016). Thus, MSCs regulate not
only transcription factors involved in neurogenesis, but also
miRNAs involved in the regulation of transcription factors.
Another miRNA that we found to be down-regulated (miR133) is involved in organogenesis, regulating the hedgehog
pathway in myogenesis (Mok et al., 2018; Yu et al., 2019).
This miRNA has been found to protect neurons when upregulated but is also involved in the remodeling of connective
tissue after injury (Xin et al., 2012; Li et al., 2018). To fully
understand the relevance of the changes induced by MSC
in the inner ear, investigation of further time points after
damage and treatment or even transcriptomics at single cell
resolution will be needed.
The biological effects of MSCs have been widely studied. MSCs
produce a wide range of growth factors, extracellular vesicles and
miRNAs that taken as a whole have a wide range of potential
effects on a tissue. The secretome of umbilical cord MSCs has
been shown to contain Ntf3, Egf, Mdk, Hbegf, Cxcl5, Cxcl2, and
Fgf9 (Hsieh et al., 2013). Interestingly, many of these factors are
involved in neurogenesis and in vitro, they up-regulate a variety
of transcription factors that enhance local release of some of
the same growth factors, thereby amplifying the repair process.
Many of the regulated genes we also identified in this study.
Immunomodulation is also a well characterized feature of MSCs
(Hsieh et al., 2013). We evaluated the potential effect of some
of these reported growth factors by modeling their regulation
of genes we saw change using IPA software. As depicted in
Figure 10, the IPA knowledge base predicts that growth factors
produced by WJCs can regulate factors such as C3, Tlr4, bcl2,
and Ttr that we identified. Fully characterizing the links between
MSC signaling and our findings is difficult since interactions of
MSCs with their target tissue may actually alter their secretome
(Drago et al., 2013). Evaluation of extracellular vesicles produced
by WJCs for the mitigation of sound trauma has demonstrated
that similar protective effects can be achieved using only the
secretome alone (Warnecke et al., 2020).
Several limitations are associated with the present study.
The study was focused on identifying the effects of MSC cell
therapy on the cochlear transcriptome after noise exposure.
Further insights could be gained by including analysis of the
transcriptome from a group of mice not exposed to noise
with and without treatment with MSC. Sound trauma-induced
changes in gene expression have been evaluated in numerous
publications (Cai et al., 2012; Patel et al., 2013). We chose
a severe form of sound trauma to test the ability of WJC
type MSCs to rescue an inner ear function. The identified
pathways are similar to the ones seen in other MSC-based
rescue of models and in analysis of TBI induced neuronal
injury. To further characterize these effects, a more moderate
sound trauma paradigm with multiple sample time points after
MSC delivery and verification of the effects using PCR and
immunohistochemistry will be needed. Despite these limitations,
main cell signaling pathways involved in MSC-mediated inner
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CONCLUSION
Delivery of WJC type MSCs after sound trauma has a significant
rescue effect on hearing. RNAseq analysis demonstrates
regulatory changes in multiple genes including genes related to
excitatory neurotransmission and the innate immune system.
Further studies using different sound trauma paradigms and
different timing of cell delivery as well as additional replicates
are needed to better characterize the effects mediated by MSCs in
the present study.
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